antiangiogenic

researchers are investigating antiangiogenic therapies for age-related macular degeneration.

antiangiogenic drugs show promise in treating certain types of cancer.

the goal of antiangiogenic treatment is to starve tumors of their blood supply.

clinical trials are evaluating the efficacy of novel antiangiogenic compounds.

antiangiogenic activity is a key mechanism in some cancer therapies.

combining antiangiogenic agents with chemotherapy can enhance treatment outcomes.

the antiangiogenic effects of bevacizumab are well-documented in ophthalmology.

targeting angiogenesis with antiangiogenic drugs is a growing area of research.

antiangiogenic therapy may reduce metastasis in some cancers.

understanding the role of angiogenesis is crucial for developing antiangiogenic strategies.

the development of new antiangiogenic agents is an ongoing process.